Virpax Pharmaceuticals (VRPX)

• Sector: Healthcare
• Industry: Pharmaceutical Preparations

About: Virpax Pharmaceuticals Inc is a preclinical stage biopharmaceutical company. The company is focused on developing pharmaceutical product candidates for pain management. Its product portfolio includes Topical metered-dose spray; Liposomal in Hydrogel encapsulation; and Enkephalin Intranasal spray.

Employees: 7

Fund manager confidence

Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)

200% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 1

93% more capital invested

Capital invested by funds: $6.5K [Q1] → $12.6K (+$6.07K) [Q2]

33% more funds holding

Funds holding: 6 [Q1] → 8 (+2) [Q2]

0.72% more ownership

Funds ownership: 0.17% [Q1] → 0.89% (+0.72%) [Q2]

50% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 2

Research analyst outlook

1 Wall Street Analyst provided 1 year price targets over the past 3 months

• Low target: $3 367% upside
• Avg. target: $3 367% upside
• High target: $3 367% upside

1 analyst rating

• positive: 1 100%
• neutral: 0 0%
• negative: 0 0%

Maxim Group Naz Rahman 18% 1-year accuracy 2 / 11 met price target

367% upside $3

Buy Upgraded

19 Jul 2024